2auz
From Proteopedia
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
| - | Starting from potent aldehyde inhibitors with poor drug properties, derivatization to semicarbazones led to the identification of a series of | + | Starting from potent aldehyde inhibitors with poor drug properties, derivatization to semicarbazones led to the identification of a series of semicarbazone-based cathepsin K inhibitors with greater solubility and better pharmacokinetic profiles than their parent aldehydes. Furthermore, a representative semicarbazone inhibitor attenuated bone resorption in an ex vivo rat calvarial bone resorption model. However, based on enzyme inhibition comparisons at neutral pH, semicarbazone hydrolysis rates, and 13C NMR experiments, these semicarbazones probably function as prodrugs of aldehydes. |
==Disease== | ==Disease== | ||
| Line 17: | Line 17: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| - | [[Category: Adkison, K | + | [[Category: Adkison, K K.]] |
| - | [[Category: Barrett, D | + | [[Category: Barrett, D G.]] |
| - | [[Category: Deaton, D | + | [[Category: Deaton, D N.]] |
| - | [[Category: Gampe, R | + | [[Category: Gampe, R T.]] |
| - | [[Category: Hassell, A | + | [[Category: Hassell, A M.]] |
| - | [[Category: Long, S | + | [[Category: Long, S T.]] |
| - | [[Category: McFadyen, R | + | [[Category: McFadyen, R B.]] |
| - | [[Category: Miller, A | + | [[Category: Miller, A B.]] |
| - | [[Category: Miller, L | + | [[Category: Miller, L R.]] |
| - | [[Category: Shewchuk, L | + | [[Category: Shewchuk, L M.]] |
[[Category: CT2]] | [[Category: CT2]] | ||
[[Category: SO4]] | [[Category: SO4]] | ||
| Line 32: | Line 32: | ||
[[Category: cysteine protease]] | [[Category: cysteine protease]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:31:17 2008'' |
Revision as of 14:31, 21 February 2008
|
Cathepsin K complexed with a semicarbazone inhibitor
Contents |
Overview
Starting from potent aldehyde inhibitors with poor drug properties, derivatization to semicarbazones led to the identification of a series of semicarbazone-based cathepsin K inhibitors with greater solubility and better pharmacokinetic profiles than their parent aldehydes. Furthermore, a representative semicarbazone inhibitor attenuated bone resorption in an ex vivo rat calvarial bone resorption model. However, based on enzyme inhibition comparisons at neutral pH, semicarbazone hydrolysis rates, and 13C NMR experiments, these semicarbazones probably function as prodrugs of aldehydes.
Disease
Known disease associated with this structure: Pycnodysostosis OMIM:[601105]
About this Structure
2AUZ is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as Cathepsin K, with EC number 3.4.22.38 Full crystallographic information is available from OCA.
Reference
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?, Adkison KK, Barrett DG, Deaton DN, Gampe RT, Hassell AM, Long ST, McFadyen RB, Miller AB, Miller LR, Payne JA, Shewchuk LM, Wells-Knecht KJ, Willard DH Jr, Wright LL, Bioorg Med Chem Lett. 2006 Feb 15;16(4):978-83. Epub 2005 Nov 15. PMID:16290936
Page seeded by OCA on Thu Feb 21 16:31:17 2008
Categories: Cathepsin K | Homo sapiens | Single protein | Adkison, K K. | Barrett, D G. | Deaton, D N. | Gampe, R T. | Hassell, A M. | Long, S T. | McFadyen, R B. | Miller, A B. | Miller, L R. | Shewchuk, L M. | CT2 | SO4 | Catk | Cysteine protease
